NASDAQ:PSTX
Delisted

Poseida Therapeutics Stock Forecast

etoro logo Buy PSTX
*Your capital is at risk
$9.50
+0 (+0%)
At Close: Apr 04, 2025

PSTX Performance

FAQ

What is the symbol for Poseida Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Poseida Therapeutics, Inc. is PSTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Poseida Therapeutics, Inc. Stock?
Based on market data through Apr 04, 2025, StockInvest.us rates Poseida Therapeutics, Inc. (PSTX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Apr 05, 2024, the price has risen 217.73%. The current 3-month trend forecast projects a fall of 0.06%.

How to buy Poseida Therapeutics, Inc. Stock?
Poseida Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Poseida Therapeutics, Inc. Stock.

What's the current price of Poseida Therapeutics, Inc. Stock?
As of the end of day on the Apr 04, 2025, the price of an Poseida Therapeutics, Inc. (PSTX) share was $9.50.

What is the 52-week high and low for Poseida Therapeutics, Inc. Stock?
The 52-week high for Poseida Therapeutics, Inc. Stock is $9.65 and the 52-week low is $1.87.

What is the market capitalization of Poseida Therapeutics, Inc. Stock?
As of the Apr 04, 2025, the market capitalization of Poseida Therapeutics, Inc. is 925.934M.
Click to get the best stock tips daily for free!
ABOUT POSEIDA THERAPEUTICS, INC.
Poseida Therapeutics
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patient...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE